Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Gilead and Jounce Therapeutics sign exclusive license pact for novel immunotherapy program

expresspharmaSeptember 02, 2020

Tag: gilead , Jounce Therapeutics , JTX-1811

PharmaSources Customer Service